Sentinel Lymph Node Working Group Data Acquisition Project

Study ID
STU 062010-176

Cancer Related
Yes

Healthy Volunteers
No

Study Sites

  • Parkland Health & Hospital System
  • UT Southwestern Ambulatory Services
  • UT Southwestern University Hospital– Zale Lipshy
  • UT Southwestern University Hospital—St. Paul

Contact
Vanessa James
214-648-7010
vanessa.james@utsouthwestern.edu

Principal Investigator
Rohit Sharma

Summary

The goal is to use the collected data to determine outcomes, identify patterns of recurrence, and identify patient or tumor related factors that influence outcome or recurrence. This will allow for a better understanding of the natural history of the diseases studied and will provide information for better therapies and follow-up schedules.

Participant Eligibility

Any patient who is treated at the University of Texas Southwestern Medical Center with Stage I or II malignant melanoma, Merkel cell carcinoma, localized squamous cell carcinoma, breast cancer or other skin malignancy who undergoes or has undergone a selective sentinel lymph node dissection procedure as part of the standard of care. Pregnant women and minors may be included in this study as it is of minimal risk provided consent can be obtained.